FindTrial
Sign In

Clinical study of Mahanimba ghan vati in obese adults of age 20-50 years

Anti-obesity activity of Leaf and stem bark of Mahanimba(Melia azedarach Linn.): In-silico, In-vitro and Exploratory clinical study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085349
Enrollment
20
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: BMI greater than 30 and less than equals to 40

Exclusion criteria

Exclusion criteria: Patients having grade II and III hepatomegaly. Patients having history of Diabetes Mellitus, PCOD, Thyroid disorders and uncontrolled Hypertension. Pregnant females and lactating women. Patients having simultaneous intake of Anticonvulsant, Beta-blockers, Corticosteroid. Patients taking any other medicines for obesity. Any study participants condition which is considered by the investigating team to jeopardize.

Design outcomes

Primary

MeasureTime frame
Improvement in Objective (Weight, BMI, Body circumference, Lipid Profile, LFT) and subjective (Gradings) parametersTimepoint: 0th day, 30th, 60th and 90th day—

Secondary

MeasureTime frame
• Change in Vitamin B12 levels. • Comparative anti-obesity activity of leaf and stem bark of Mahanimba.Timepoint: 0th day, 30th, 60th and 90th day—

Countries

India

Contacts

Public ContactDr Aman Singhal

All India Institute of Ayurveda

drshivanighildiyal@gmail.com8765363310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026